{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:29:23Z","timestamp":1770535763402,"version":"3.49.0"},"reference-count":28,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Funda\u00e7\u00e3o Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: In patients with cystic fibrosis (pwCF) acid suppression therapy, gastrointestinal dysmotility, and post-operative bowel status, may predispose to the development of small intestinal bacterial overgrowth (SIBO). SIBO may continue to be present in the progression of the disease even on modulators. Breath testing is the most simple, non-invasive and available method for diagnosing SIBO. There are some divergencies over the operational procedures used to carry out and interpret breath tests in pwCF.  Objective: We performed a systematic review of SIBO in pwCF to assess the methods used in breath tests and the existence of causal relationship between SIBO and following CF co-morbidities: liver disease, fat absorption, and eating disorders.  Methods: We searched the PubMed, Cochrane Library, Embase, LILACS, MEDLINE, OpenGray, medRxiv, Google Scholar, and CAPES databases up to March 20, 2024. We selected clinical cohort and case-control studies to assess SIBO in cwCF. We selected studies that met the following criteria: (1) participants - children and adolescents diagnosed with CF; (2) intervention - assessment of SIBO using H2 and CH4 breath tests; (3) control - patients without SIBO; and (4) outcome - assessment of breath tests for SIBO diagnosis and the causal relationship between SIBO and CF co-morbidities. The PRISMA statement was used to report the search. QUADAS 2 tool was used for assessing the quality of each study methodology. The protocol for this review was registered in the Prospective Registration of Systematic Review Database (CRD42024503593).  Results: The search strategy identified 279 studies. After screening titles and abstracts, 36 studies were selected for full-text review and 27 were excluded; nine studies involving 206 pwCFs were reviewed. All nine studies used H2 breath tests as a diagnostic method for SIBO, and five of them used a combined H2\/CH4 test. There was no consistency in the timing of cessation of antibiotic therapy prior to testing. All patients performed the test after an overnight fast. A basal sample was collected prior to substrate (glucose or lactulose) ingestion, which ranged from 7 to 20 ppm. There was great variability between respiratory sample collection times, being times 0, 15, 30, 45, 60, 90, and 120 minutes the most used protocol. The methods for performing breath tests varied widely, making it difficult to reach conclusions on the role of SIBO as a co-morbidity in pwCF. There was no association between increased serum AST, ALT, and GGT levels and positive breath tests. There was no agreement regarding the role of SIBO and nutritional deficiency, but a reduction in fat absorption and the presence of hyporexia have been described under this condition.  Conclusion: Data on assessment of SIBO in pwCF is limited by the small number of studies available, the lack of appropriate controls in some studies, and the varying test methodology and diagnostic cut-offs applied. Protocols to investigate and diagnosing SIBO in pwCF need to be developed.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612024-110","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:04:02Z","timestamp":1746183842000},"source":"Crossref","is-referenced-by-count":1,"title":["SMALL INTESTINAL BACTERIAL OVERGROWTH IN PEOPLE WITH CYSTIC FIBROSIS: SYSTEMATIC REVIEW"],"prefix":"10.1590","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0284-0424","authenticated-orcid":false,"given":"Maria Lidiane Lavor","family":"LANDIM","sequence":"first","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3387-5642","authenticated-orcid":false,"given":"Jos\u00e9 Dirceu","family":"RIBEIRO","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1796-3068","authenticated-orcid":false,"given":"Daniela de Souza Paiva","family":"BORGLI","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9983-4394","authenticated-orcid":false,"given":"Danielle Rossana Queiroz Martins","family":"BONILHA","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5504-4746","authenticated-orcid":false,"given":"Elizete Aparecida","family":"LOMAZI","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5237-7227","authenticated-orcid":false,"given":"Maria de F\u00e1tima Correa Pimenta","family":"SERVIDONI","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2020.06.090","article-title":"Clinical Practice Guidelines AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review","volume":"159","author":"Quigley EMM","year":"2020","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fped.2019.00363","article-title":"Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review","volume":"7","author":"Avelar Rodriguez D","year":"2019","journal-title":"Front Pediatr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MPG.0b013e31802c0ceb","article-title":"Risk factors for small bowel bacterial overgrowth in cystic fibrosis","volume":"44","author":"Fridge JL","year":"2007","journal-title":"J Pediatr Gastroenterol and Nutr"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"12S15","DOI":"10.1016\/S0929-693X(17)30058-1","article-title":"Atteinte h\u00e9patique, digestive, prise en charge nutritionnelle et troubles de l\u2019oralit\u00e9 chez l\u2019enfant atteint de mucoviscidose","volume":"23","author":"Debray D","year":"2016","journal-title":"Arch Pediatr"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MOG.0000000000000971","article-title":"Small intestinal bacterial overgrowth: current update","volume":"39","author":"Zafar H","year":"2023","journal-title":"Curr Opin Gastroenterol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.advms.2014.09.001","article-title":"Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO","volume":"60","author":"Miazga A","year":"2015","journal-title":"Adv Med Sci"},{"key":"ref7","first-page":"631","article-title":"Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection","volume":"56","author":"Lisowska A","year":"2009","journal-title":"Acta Biochim Pol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MPG.0000000000003245","article-title":"An ESPGHAN Position Paper on the Use of Breath Testing in Paediatric Gastroenterology","volume":"74","author":"Broekaert IJ","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00535-018-1509-4","article-title":"The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin","volume":"54","author":"Furnari M","year":"2019","journal-title":"J Gastroenterol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40272-022-00509-y","article-title":"An Update on CFTR Modulators as New Therapies for Cystic Fibrosis","volume":"24","author":"King JA","year":"2022","journal-title":"Paediatr Drugs"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2022.10.003","article-title":"Elexacaftor\/tezacaftor\/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI","volume":"22","author":"Schwarzenberg SJ","year":"2023","journal-title":"Cyst Fibros"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jcf.2021.11.014","article-title":"Intestinal function and transit are associated with dysbiosis of gut microbiota dysbiosis in cystic fibrosis","volume":"21","author":"Marsh R","year":"2022","journal-title":"J Cyst Fibros"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260479","article-title":"Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis","volume":"16","author":"Kuang L","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MPG.0000000000003459","article-title":"Changes in glucose breath test results in cystic fibrosis patients treated for 1 month of Lumacaftor\/Ivacaftor","volume":"75","author":"Gabel ME","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref15","first-page":"345","article-title":"Gastrointestinal complications of cystic fibrosis","volume":"30","author":"Ng C","year":"2020","journal-title":"Paediatrics and Health"},{"key":"ref16","series-title":"Diretrizes metodol\u00f3gicas: elabora\u00e7\u00e3o de revis\u00e3o sistem\u00e1tica e meta-an\u00e1lise de ensaios cl\u00ednicos randomizados","year":"2021"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting PF","year":"2011","journal-title":"Ann Intern Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcf.2011.06.008","article-title":"Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth","volume":"10","author":"Lisowska A","year":"2011","journal-title":"J Cyst Fibros"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3109\/00365513.2010.486869","article-title":"Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis","volume":"70","author":"Lisowska A","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"key":"ref20","first-page":"501","article-title":"Improvement of intestinal function in cystic fibrosis patients using probiotics","volume":"69","author":"Infante Pina D","year":"2008","journal-title":"An Pediatr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s10620-008-0559-5","article-title":"Application of the glucose hydrogen breath test for the detection of bacterial overgrowth in patients with cystic fibrosis--a reliable method?","volume":"54","author":"Schneider AR","year":"2009","journal-title":"Dig Dis Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1440-1754.1998.00159.x","article-title":"Bowel dysfunction in cystic fibrosis: importance of breath testing","volume":"34","author":"Lewindon PJ","year":"1998","journal-title":"J Paediatr Child Health"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00311-21","article-title":"The Gut-Lung Axis in Cystic Fibrosis","volume":"203","author":"Price CE","year":"2021","journal-title":"J Bacteriol"},{"key":"ref24","first-page":"00076","article-title":"Impact of highly effective modulator therapy on gastrointestinal symptoms and features in people with cystic fibrosis","volume":"S1526-0542","author":"Cecchetti M","year":"2024","journal-title":"Paediatr Respir Rev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1002\/ppul.26913","article-title":"The gastrointestinal microbiome, small bowel bacterialovergrowth, and microbiome modulators in cystic fibrosis","volume":"59","author":"Green N","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260479","article-title":"Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis","volume":"16","author":"Kuang L","year":"2021","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcf.2017.07.014","article-title":"Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the cystic fibrosis intestine","volume":"16","author":"Dorsey J","year":"2017","journal-title":"J Cyst Fibros"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11894-017-0546-0","article-title":"The enigmatic gut in cystic fibrosis: linking inflammation, dysbiosis, and the increased risk of malignancy","volume":"19","author":"Garg M","year":"2017","journal-title":"Curr Gastroenterol Rep"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Sobrecrescimento bacteriano no intestino delgado em pacientes com fibrose c\u00edstica: revis\u00e3o sistem\u00e1tica"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032025000101100&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:04:46Z","timestamp":1746183886000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032025000101100&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"alternative-id":["S0004-28032025000101100"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612024-110","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e24110"}}